What Nephrocare India does

Nephro Care India Ltd (NSE/BSE: NEPHROCARE) is a Kolkata-based, publicly listed kidney care provider operating a 360-degree holistic care model that spans hemodialysis, home/peritoneal dialysis, kidney transplantation (including ABO-incompatible and deceased-donor), conservative nephrology, and disease-specific specialty clinics for conditions such as ADPKD, diabetic kidney disease, and glomerular disease. The company is led by founder and Managing Director Dr. Pratim Sengupta (MD Medicine, DM Nephrology), who also serves as Advisor to the Government of India's National Organ & Tissue Transplant Organisation and holds nephrology leadership roles at ILS Group of Hospital and Bellevue Clinic, Kolkata. The clinical offering is supported by an integrated ecosystem of sub-brands: Carepath Diagnostics (biochemistry, pathology, microbiology, transplant immunology, digital radiology with same-day reporting and home collection), Caremeds Pharmacy (in-house pharmacy with doorstep delivery), and Kidney Care Society (community outreach and awareness), plus a three-tier membership program (Platinum/Gold/Silver) and lifestyle/yoga therapy services.

The company generates revenue from a mix of recurring clinical services (dialysis subscriptions, membership fees, transplant programs) and transactional services (diagnostics, pharmacy, consultations, home care packages) across four clinic locations in West Bengal (Salt Lake/Kolkata headquarters, Shyambazar, Chandannagar, and Alipurduar) with a stated expansion target of 22 high-end kidney care facilities by March 2026 and 300 clinics across India over 8-10 years. Its go-to-market is sales-led and clinic-based, combining direct physician consultations, home-based care, community awareness events, content marketing (blog, Dr. Pratim's podcast), and a franchise program for pan-India rollout. In December 2025, the company completed an IPO on BSE and NSE at a price band of Rs 438-460 per share, raising approximately Rs 871.05 crore to fund the expansion plan, following a Rs 8.08 crore pre-IPO round in December 2023 led by HDFC's Deepak Parekh.

Name

Nephrocare India

Legal name

Nephro Care India Ltd

Website

https://nephrocareindia.com

Company type

Public

Operating status

Operating

Headcount range

51–100 employees

Short description

Nephro Care India Ltd (NSE: NEPHROCARE) is a Kolkata-based, publicly listed kidney care provider offering holistic renal services — dialysis, transplantation, diagnostics, pharmacy, and lifestyle therapy — to CKD and end-stage renal disease patients across West Bengal, with plans to scale to 300 pan-India clinics.

Ownership category

akta.pro rank

Product category

Kidney Care / Nephrology Services

NAICS

Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082)

akta.pro primary industry

General Nephrology Practice (HLAKAHAA)

akta.pro secondary industries

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC), Outpatient Dialysis & Kidney Care Centers (HLAFABAE), Home Dialysis Support & Training Providers (HLAFAEAG), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC)

Keywords

• Kidney care services
• Dialysis treatment
• Nephrology clinic
• Kidney transplantation
• Renal diagnostics

Headquarters

HQ city

Kolkata

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Services: Revenue from nephrology consultations, dialysis treatments (hemodialysis, peritoneal dialysis), kidney transplantation services, and vascular surgery procedures
2. Diagnostic Services: Pathology, radiology, and imaging services including biochemistry, clinical pathology, microbiology, transplant immunology, and digital X-ray
3. Pharmacy (Caremeds): In-house pharmacy with doorstep medicine delivery across multiple locations
4. Membership Programs: Platinum, Gold, and Silver membership tiers offering discounted consultations, pathology tests, medications, and exclusive benefits
5. Home Care Services: Home-based dialysis, doctor-at-home packages, and ambulance services

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Nephrocare India operates a premier kidney care center providing comprehensive nephrology services including hemodialysis, home/peritoneal dialysis, kidney transplantation, and conservative nephrology for chronic kidney disease. The offering is anchored on a 360-degree holistic approach that combines advanced medical treatment with nutrition counseling, yoga therapy, and mental/emotional support, supported by in-house diagnostics (Carepath Diagnostics), in-house pharmacy with doorstep delivery (Caremeds), and disease-specific specialty clinics.

Product overview

Nephro Care India Ltd is a premier kidney care provider offering a comprehensive, 360-degree holistic approach to treating kidney diseases. The company's portfolio centers around core nephrology services including hemodialysis, home/peritoneal dialysis, kidney transplantation, and conservative nephrology for chronic kidney disease management. Supporting these core services are diagnostic capabilities through Carepath Diagnostics (biochemistry, pathology, microbiology, transplant immunology, digital radiology), in-house pharmacy delivery via Caremeds, and clinical nutrition and yoga therapy programs. The company operates specialty clinics for ADPKD, diabetic kidney disease, glomerular disease, urology conditions, vascular surgery, and cardiology. Additional offerings include a three-tier membership program, online lab reports, appointment booking, and home care services. The integrated model combines in-center treatment at multiple locations (Salt Lake, Chandannagar, Shyambazar, Alipurduar) with home-based care options and wellness programs to address the full spectrum of renal care from prevention to advanced kidney failure treatment.

Differentiator

Problem solved

Functional benefit

Brands

• Carepath Diagnostics: Diagnostic services including biochemistry, clinical pathology, microbiology, transplant immunology, and drug level monitoring.
• Caremeds Pharmacy
• Kidney Care Society

Products and services

• Hemodialysis Services In-center hemodialysis treatment using multiple dialysis machines under the supervision of skilled technicians, with both chair and bed facilities available for end-stage renal disease patients.
• Home Dialysis and Peritoneal Dialysis
• Kidney Transplantation
• Conservative Nephrology
• Carepath Diagnostics
• Digital Radiology
• Caremeds Pharmacy
• Clinical Nutrition and Lifestyle Education
• Lifestyle and Yoga Therapy
• Urology Clinic
• Vascular Surgery Clinic
• Cardiology Services
• Home Care Services
• Specialty Clinics (ADPKD, Diabetic Kidney Disease, Glomerular Disease)
• Women Welfare Services
• Membership Program (Platinum / Gold / Silver)

Quantifiable outcome

• Patients able to avoid or reduce dialysis frequency through comprehensive care
• +1 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Vivacity HospitalscoreStrategic or Co-development PartnerVivacity Hospitals is a brand partner indicated by logo placement on the Nephrocare India website, suggesting a collaborative relationship in healthcare service delivery.
• Bellevue CliniccoreStrategic or Co-development PartnerDr. Pratim Sengupta serves as Nephrologist & In-charge Organ Transplant Programme at Bellevue Clinic, Kolkata, indicating a collaborative arrangement for transplant services.
• ILS Group of HospitalcoreStrategic or Co-development PartnerDr. Pratim Sengupta serves as Director of Nephrology & Renal Transplant Programme at ILS Group of Hospital, indicating a collaborative relationship for nephrology and transplant services.
• EFC LimitedminorOthersEFC Limited provides corporate office space at Millenium City, IT Park, Tower 2 in Kolkata, serving as the company's corporate office location.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• NephroPlus: India's largest independent dialysis chain, operating hundreds of centers across the country. Directly competes with Nephrocare India in hemodialysis and kidney care services with a similarly patient-centric operating model but at significantly greater scale.

Broad incumbents

• DaVita India: Global dialysis giant with Indian operations. Competes in the same dialysis and CKD management space as Nephrocare, but with global scale, deeper capital, and broader payor relationships.
• Fresenius Medical Care: World's largest dialysis services and products company, with significant India presence. Overlaps with Nephrocare in dialysis treatment delivery, while also supplying equipment to the broader market.
• Apollo Hospitals: India's largest hospital chain, with nephrology and dialysis programs across its network. Provides a comparable nephrology service offering as part of a much broader multi-specialty hospital portfolio.
• Fortis Healthcare: Major Indian hospital chain operating nephrology and transplant programs. Comparable to Nephrocare in offering kidney transplantation and dialysis within a multi-specialty hospital setting.
• Max Healthcare: Leading North India hospital network with established nephrology, dialysis, and kidney transplant services. Comparable to Nephrocare in nephrology and transplant offerings, but with a much larger multi-specialty footprint.
• Medanta: Multi-specialty hospital group with strong nephrology and renal transplant programs, including complex transplant cases. Comparable to Nephrocare in specialty kidney care and transplantation.
• Narayana Health: Large Indian hospital chain known for affordable specialty care including nephrology and dialysis. Comparable in kidney care service offering, with a focus on cost-effective treatment at national scale.
• Manipal Hospitals: Large hospital chain with nephrology and transplant services across India. Comparable in offering kidney disease treatment and transplantation as part of a broader multi-specialty portfolio.

Emerging players

• Renalyx: Emerging Indian kidney care and dialysis startup. Comparable to Nephrocare as a nephrology-focused player targeting India's under-penetrated dialysis market, though at a smaller scale.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/NephrocareIndia
• Facebookfacebook.com/NephroCareIndia
• LinkedInlinkedin.com/company/nephrocare-india

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nephrocare India